These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
293 related items for PubMed ID: 15488885
1. Impaired high density lipoprotein antioxidant activity in healthy postmenopausal women. Zago V, Sanguinetti S, Brites F, Berg G, Verona J, Basilio F, Wikinski R, Schreier L. Atherosclerosis; 2004 Nov; 177(1):203-10. PubMed ID: 15488885 [Abstract] [Full Text] [Related]
2. HDL oxidability and its protective effect against LDL oxidation in Type 2 diabetic patients. Sanguinetti SM, Brites FD, Fasulo V, Verona J, Elbert A, Wikinski RL, Schreier LE. Diabetes Nutr Metab; 2001 Feb; 14(1):27-36. PubMed ID: 11345163 [Abstract] [Full Text] [Related]
6. Elevated HDL2-paraoxonase and reduced CETP activity are associated with a dramatically lower ratio of LDL-cholesterol/total cholesterol in a hypercholesterolemic and hypertriglyceridemic patient. Lee JH, Park JH, Lee SH, Kim JR, Cho KH. Int J Mol Med; 2010 Jun; 25(6):945-51. PubMed ID: 20428800 [Abstract] [Full Text] [Related]
7. The functional and compositional properties of lipoproteins are altered in patients with metabolic syndrome with increased cholesteryl ester transfer protein activity. Park KH, Shin DG, Kim JR, Hong JH, Cho KH. Int J Mol Med; 2010 Jan; 25(1):129-36. PubMed ID: 19956911 [Abstract] [Full Text] [Related]
8. Inverse correlation of serum paraoxonase and homocysteine thiolactonase activities and antioxidant capacity of high-density lipoprotein with the severity of cardiovascular disease in persons with type 2 diabetes mellitus. Lakshman MR, Gottipati CS, Narasimhan SJ, Munoz J, Marmillot P, Nylen ES. Metabolism; 2006 Sep; 55(9):1201-6. PubMed ID: 16919539 [Abstract] [Full Text] [Related]
9. High density lipoprotein is an inappropriate substrate for hepatic lipase in postmenopausal women. Zago V, Miksztowicz V, Cacciagiú L, Basilio F, Berg G, Schreier L. Clin Chim Acta; 2012 Dec 24; 414():142-5. PubMed ID: 22975205 [Abstract] [Full Text] [Related]
10. Human apolipoprotein A-II enrichment displaces paraoxonase from HDL and impairs its antioxidant properties: a new mechanism linking HDL protein composition and antiatherogenic potential. Ribas V, Sánchez-Quesada JL, Antón R, Camacho M, Julve J, Escolà-Gil JC, Vila L, Ordóñez-Llanos J, Blanco-Vaca F. Circ Res; 2004 Oct 15; 95(8):789-97. PubMed ID: 15388641 [Abstract] [Full Text] [Related]
11. Cholesteryl ester transfer protein and lecithin:cholesterol acyltransferase activities in hispanic and anglo postmenopausal women: associations with total and regional body fat. Greaves KA, Going SB, Fernandez ML, Milliken LA, Lohman TG, Bassford T, McNamara DJ. Metabolism; 2003 Mar 15; 52(3):282-9. PubMed ID: 12647264 [Abstract] [Full Text] [Related]
12. Protective effect of paraoxonase activity in high-density lipoproteins against erythrocyte membranes peroxidation: a comparison between healthy subjects and type 1 diabetic patients. Ferretti G, Bacchetti T, Busni D, Rabini RA, Curatola G. J Clin Endocrinol Metab; 2004 Jun 15; 89(6):2957-62. PubMed ID: 15181084 [Abstract] [Full Text] [Related]
13. Cholesteryl ester transfer protein (CETP) inhibition beyond raising high-density lipoprotein cholesterol levels: pathways by which modulation of CETP activity may alter atherogenesis. Klerkx AH, El Harchaoui K, van der Steeg WA, Boekholdt SM, Stroes ES, Kastelein JJ, Kuivenhoven JA. Arterioscler Thromb Vasc Biol; 2006 Apr 15; 26(4):706-15. PubMed ID: 16439711 [Abstract] [Full Text] [Related]
14. Increased low-density lipoprotein oxidation and impaired high-density lipoprotein antioxidant defense are associated with increased macrophage homing and atherosclerosis in dyslipidemic obese mice: LCAT gene transfer decreases atherosclerosis. Mertens A, Verhamme P, Bielicki JK, Phillips MC, Quarck R, Verreth W, Stengel D, Ninio E, Navab M, Mackness B, Mackness M, Holvoet P. Circulation; 2003 Apr 01; 107(12):1640-6. PubMed ID: 12668499 [Abstract] [Full Text] [Related]
15. Human serum paraoxonase (PON 1) is inactivated by oxidized low density lipoprotein and preserved by antioxidants. Aviram M, Rosenblat M, Billecke S, Erogul J, Sorenson R, Bisgaier CL, Newton RS, La Du B. Free Radic Biol Med; 1999 Apr 01; 26(7-8):892-904. PubMed ID: 10232833 [Abstract] [Full Text] [Related]
16. Paraoxonase activity in high-density lipoproteins: a comparison between healthy and obese females. Ferretti G, Bacchetti T, Moroni C, Savino S, Liuzzi A, Balzola F, Bicchiega V. J Clin Endocrinol Metab; 2005 Mar 01; 90(3):1728-33. PubMed ID: 15613429 [Abstract] [Full Text] [Related]
17. Effects of estrogen-only therapy on LDL oxidation in women with hysterectomy: does paraoxonase genotype play a role? Akçay YD, Sagin FG, Sendağ F, Oztekin K, Sozmen EY. Maturitas; 2006 Feb 20; 53(3):325-32. PubMed ID: 16023312 [Abstract] [Full Text] [Related]
18. Evidence for a paraoxonase-independent inhibition of low-density lipoprotein oxidation by high-density lipoprotein. Graham A, Hassall DG, Rafique S, Owen JS. Atherosclerosis; 1997 Dec 20; 135(2):193-204. PubMed ID: 9430369 [Abstract] [Full Text] [Related]
19. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits. Zhang B, Fan P, Shimoji E, Xu H, Takeuchi K, Bian C, Saku K. Arterioscler Thromb Vasc Biol; 2004 Oct 20; 24(10):1910-5. PubMed ID: 15331428 [Abstract] [Full Text] [Related]
20. Lipoprotein composition in NIDDM: effects of dietary oleic acid on the composition, oxidisability and function of low and high density lipoproteins. Dimitriadis E, Griffin M, Collins P, Johnson A, Owens D, Tomkin GH. Diabetologia; 1996 Jun 20; 39(6):667-76. PubMed ID: 8781762 [Abstract] [Full Text] [Related] Page: [Next] [New Search]